Skip to main content
Shilpan Shah, MD, Oncology, Houston, TX

ShilpanSatishShahMD

Oncology Houston, TX

Hematologic Oncology

Physician

Telehealth Available

Overview of Dr. Shah

Dr. Shilpan Shah is an oncologist in Houston, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Hospital, Houston Methodist Sugar Land Hospital, Houston Methodist Willowbrook Hospital, Houston Methodist Baytown Hospital, Houston Methodist West Hospital, Houston Methodist The Woodlands Hospital, Houston Methodist Clear Lake Hospital, and Memorial Hermann - Texas Medical Center. He received his medical degree from Baroda Medical College and has been in practice 15 years. He is one of 90 doctors at Houston Methodist Hospital and one of 29 doctors at Memorial Hermann - Texas Medical Center who specialize in Oncology. He has more than 10 publications and over 200 citings.

Education & Training

  • University of Texas M.D. Anderson Cancer Center
    University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia, 2013 - 2014
  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalChief Residency, Internal Medicine, 2009 - 2010
  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2006 - 2009
  • Baroda Medical College
    Baroda Medical CollegeClass of 2002

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2012 - 2026
  • NY State Medical License
    NY State Medical License 2009 - 2013
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Primary Cutaneous Anaplastic Large-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis from 2005-2016
    Shilpan S. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019